GRK-2 inhibitors (Xsira)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGRK-2 inhibitors (Xsira)
Drug Alias Namebeta-adrenoceptor related kinase-1 inhibitors (Xsira)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-adrenergic receptor kinase 1 inhibitors
TargetsBeta-adrenergic receptor kinase 1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXsira Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXsira Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A